3 completed, 2 terminated. 5 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Terminated 2 |
| Phase 1 | 3 | Completed 3 |
Follow Diffusion Pharmaceuticals Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Trans Sodium Crocetinate in Patients With Interstitial Lung Disease Trans Sodium Crocetinate, Placebo - Interstitial Lung Disease | Phase 2 | Terminated | Diffusion Pharmaceuticals Inc | 18 | 2021-12-02 | 2022-08-10 |
| Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects Trans Sodium Crocetinate, Normal saline - SARS-CoV-2 (Covid19) | Phase 1 / Phase 2 | Completed | Diffusion Pharmaceuticals Inc | 25 | 2020-09-10 | 2022-04-14 |
| Efficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected Stroke Trans-Sodium Crocetinate, Placebo - Stroke, Acute | Phase 2 | Terminated | Diffusion Pharmaceuticals Inc | 6 | 2019-08-22 | 2021-06-18 |
| Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma Trans Sodium Crocetinate (TSC) - Glioblastoma, GBM | Phase 1 / Phase 2 | Completed | Diffusion Pharmaceuticals Inc | 59 | 2012-02-01 | 2017-07-14 |
| Safety, Efficacy, and Pharmacokinetics (PK) Study of Trans Sodium Crocetinate (TSC) in Patients With Intermittent Claudication Trans sodium crocetinate (TSC), 0.9% normal saline - Intermittent Claudication | Phase 1 / Phase 2 | Completed | Diffusion Pharmaceuticals Inc | 48 | 2008-08-01 | 2011-07-29 |
Atherosclerosis (1) · Brain Neoplasms (1) · COVID-19 (1) · Glioblastoma (1) · Glioma (1) · Hypoxia (1) · Intermittent Claudication (1) · Lung Diseases, Interstitial (1) · Peripheral Arterial Disease (1) · Stroke (1)
trans-sodium crocetinate (5) · Saline Solution (2) · Sodium Chloride (1)
United States (4) · Romania (1)
Adrian Streinu Cercel, MD (1) · Andrew Southerland, MD (1) · David R. Jones, M.D. (1) · Jeffrey Saver, MD (1) · Karen Johnston, MD (1) · Nerses Sanossian, MD (1)